PD64-06 REDO ROBOTIC PARTIAL NEPHRECTOMY FOR RECURRENT RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS

Abstract

You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy VI (PD64)1 Sep 2021PD64-06 REDO ROBOTIC PARTIAL NEPHRECTOMY FOR RECURRENT RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS Alp T. Beksac, Umberto Carbonara, Mahmoud Abou Zeinab, Sij Hemal, Margaret Meagher, Alessandro Tafuri, Gabriele Tuderti, Alessandro Antonelli, Riccardo Autorino, Giuseppe Simone, Ithaar Derweesh, and Jihad Kaouk Alp T. BeksacAlp T. Beksac More articles by this author , Umberto CarbonaraUmberto Carbonara More articles by this author , Mahmoud Abou ZeinabMahmoud Abou Zeinab More articles by this author , Sij HemalSij Hemal More articles by this author , Margaret MeagherMargaret Meagher More articles by this author , Alessandro TafuriAlessandro Tafuri More articles by this author , Gabriele TudertiGabriele Tuderti More articles by this author , Alessandro AntonelliAlessandro Antonelli More articles by this author , Riccardo AutorinoRiccardo Autorino More articles by this author , Giuseppe SimoneGiuseppe Simone More articles by this author , Ithaar DerweeshIthaar Derweesh More articles by this author , and Jihad KaoukJihad Kaouk More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002108.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: As the experience with robotic partial nephrectomy (RPN) grows, the indications have expanded to incorporate previously operated ipsilateral kidneys with recurrent renal masses. We sought to analyze the outcomes of redo RPN in patients with a recurrent renal mass. METHODS: Using a multi-institutional series, the data of 72 patients who underwent RPN for a recurrent renal mass between 2010 and 2020 was retrospectively analyzed. Patients with familial renal cell carcinoma and multiple renal tumors were excluded. Major complication defined by Clavien grade >2. Median follow up was 28.5 months. Baseline demographics, clinical and tumor characteristics, perioperative and postoperative outcomes are reported. RESULTS: Our cohort consisted of a combination of previous thermal ablation, laparoscopic, open and robotic surgeries. Median RENAL score was 8. In our cohort, 20% had hilar tumors and 9.7% had a solitary kidney. Partial nephrectomy was completed in all cases. Two cases (2.8%) were converted to open surgery. None of the cases were converted to radical nephrectomy intraoperatively. One patient underwent radical nephrectomy postoperatively due to bleeding. Transfusion rate was 5.9% and major complication rate was 8.3%. Median length of stay was 3 days. Acute kidney injury was 35.1% at discharge, however eGFR preservation was 90.8% at one year follow up. Positive surgical margin rate was 9.5%. Recurrence was seen in 14 patients (15.2%), however only one patient had local recurrence (1.4%). CONCLUSIONS: In experienced hands, RPN is an effective approach to treat recurrent renal masses with promising perioperative and functional outcome. Patients should be carefully monitored for distant recurrence. Source of Funding: None © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1145-e1146 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alp T. Beksac More articles by this author Umberto Carbonara More articles by this author Mahmoud Abou Zeinab More articles by this author Sij Hemal More articles by this author Margaret Meagher More articles by this author Alessandro Tafuri More articles by this author Gabriele Tuderti More articles by this author Alessandro Antonelli More articles by this author Riccardo Autorino More articles by this author Giuseppe Simone More articles by this author Ithaar Derweesh More articles by this author Jihad Kaouk More articles by this author Expand All Advertisement Loading ...